About Douglas Berger Psychiatrist Tokyo

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Dr. Douglas Berger, M.D., Ph.D. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine. And now, Dr. Douglas Berger is a fully bilingual American board certified psychiatrist,  as well as the Director of the Tokyo Meguro Counseling Center.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page as well as the Tokyo Meguro Counseling Center’s page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Contact Douglas Berger psychiatrist Tokyo by visiting this page

Counseling Tokyo: to take money from patients for an unproven activity? https://t.co/Hpqw4c2xBN

Tokyo Counseling Service: Catagorizing personality is neither simple nor appropriate. https://t.co/mONoUMDt2X

Douglas Berger Tokyo psychiatrist: brain changes on Mindfulness; subject no and size isn't clear https://t.co/ymXnvrHKzh

Douglas Berger Tokyo psychiatrist: bridge for brain changes seen in mindfulness & efficacy for psychiatric illness https://t.co/K6k7BCrQt4

There is no clear bridge for brain changes seen in mindfulness & efficacy for psychiatric illness: https://t.co/ASq8y9Jzo5. The subjects are all healthy people, making the connection to various psychiatric illness speculation. Us: https://t.co/2cyfo9FRgl

Load More...

Tokyo Counseling Service: Catagorizing Personality, not simple. https://t.co/UhyfW2fHb9 @YouTubeさんから

The no of subjects with brain changes on Mindfulness is not reported: https://t.co/CC4HlhldEi. If only a few subjects had large changes, what does that really say? It is also not clear what the size of this change means clinically or physiologically. Us: https://t.co/WLIjKdXqXL

Brain changes in Mindfulness Based therapy was unblinded with only 16 subjects: https://t.co/CC4HlhldEi. If you look at many brain sections you may find something by chance, you need to half your p value for each section looked at, not done here. Us: https://t.co/kbQF1wSzGN

Tokyo Counseling Service on ADHD https://t.co/LPwy8DzMbB @YouTubeさんから

Antidepressants show efficacy under double blind vs blind placebo because blinding filters out hope and expectation. Neither randomization nor blind assessment can make up for the loss of control from no-blind, no placebo conditions. Us: https://t.co/tReJReVhnP

Load More...